#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor IX deficiency Myeloproliferative neoplasm Amyotrophic lateral sclerosis gene carrier Angiosarcoma non-metastatic Glycogen storage disease type V Familial haemophagocytic lymphohistiocytosis Hypocalcaemia Autoimmune disorder Metastases to central nervous system Autoimmune demyelinating disease Systemic candida Cholestatic pruritus Pemphigoid Juvenile psoriatic arthritis Neuroendocrine cell hyperplasia of infancy More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Diagnostics Angiosarcoma metastatic Osteosarcoma – Trials in Disease Sjogren’s syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Nephrotic syndrome – Treatment Alport’s syndrome – Life with Disease Hairy cell leukaemia recurrent – Diagnostics Paraneoplastic neurological syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Losartan Glatiramer Acetate Bepranemab Resatorvid Gedatolisib Lenomorelin POLYSORBATE 80 Frexalimab Ferumoxytol OXYBUTYNIN HYDROCHLORIDE Clonazepam Tirzepatide A24110He Star-0215 Phenylephrine Hydrochloride Vibegron Anhydrous Cholestyramine Potato Starch Etranacogene Dezaparvovec Keto-Isoleucine Calcium More therapies…

    Learn about Your Condition

    Actinic keratosis Alcoholic liver disease Infertility Connective tissue disorder Nocturia Cardiac disorder Haemoglobinuria Short stature Death neonatal Nephropathy Adenosquamous cell lung cancer Primary hyperaldosteronism Renal transplant Neuroblastoma recurrent Plasmablastic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • A Study of Bevacizumab for Adults with Long-Lasting Breathing Problems After COVID-19 Infection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Bevacizumab
    France

  • Study of Tenofovir Alafenamide as Add-on Treatment to Anti-CD20 Therapy in Multiple Sclerosis Patients to Reduce Neuronal Damage

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Tenofovir Alafenamide
    Norway

  • Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    • Polymyalgia rheumatica
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    • Pneumonia bacterial
    • Pneumonia
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on the Safety and Immune Response of OVX033 Vaccine for Adults with Sarbecovirus Disease

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Sodium Chloride
    France
Previous Page
1 … 17 18 19 20 21 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!